Gene · 3669
Papers4,236
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 4,236
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TDRD3 is an antiviral restriction factor that promotes IFN signaling with G3BP1. | PLoS Pathog | 2022 | 35085371 | PubTator, text mining | PubMed |
| Platelets modulate CD4+ T-cell function in COVID-19 through a PD-L1 dependent mechanism. | Br J Haematol | 2022 | 35076084 | PubTator, text mining | PubMed |
| Atypical "accelerated" chronic lymphocytic leukemia with abnormal lymphocyte chromatin clumping, bone involvement, and exceptional response to Imbruvica. | Cancer Rep (Hoboken) | 2022 | 35075812 | PubTator, text mining | PubMed |
| Prognostic implications of N6-methyladenosine RNA regulators in breast cancer. | Sci Rep | 2022 | 35075167 | PubTator, text mining | PubMed |
| Coexistence of T-Large Granular Lymphocyte Leukemia and Peripheral T Cell Lymphoma-NOS with Indolent Behavior. | Mediterr J Hematol Infect Dis | 2022 | 35070213 | PubTator, text mining | PubMed |
| Optimized Flow Cytometry Strategy for Phenotyping Intramuscular Leukocytes: Application to the Evaluation of Myopathological Processes. | J Neuropathol Exp Neurol | 2022 | 35066584 | PubTator, text mining | PubMed |
| Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19. | Nat Commun | 2022 | 35064122 | PubTator, text mining | PubMed |
| Immune Profiling of COVID-19 in Correlation with SARS and MERS. | Viruses | 2022 | 35062368 | PubTator, text mining | PubMed |
| Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer. | J Ovarian Res | 2022 | 35057848 | PubTator, text mining | PubMed |
| [Establishment of 14-Color Panel for Determining Leukocyte Subsets in Human Peripheral Blood with Flow Cytometry]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2022 | 35048612 | PubTator, text mining | PubMed |
| BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes. | Haematologica | 2022 | 35045695 | PubTator, text mining | PubMed |
| Quantifying protein abundance on single cells using split-pool sequencing on DNA-barcoded antibodies for diagnostic applications. | Sci Rep | 2022 | 35042926 | PubTator, text mining | PubMed |
| Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report. | Transplant Cell Ther | 2022 | 35042013 | PubTator, text mining | PubMed |
| Severe ARDS Secondary to Legionella Pneumonia Requiring VV ECMO in the Setting of Newly Diagnosed Hairy Cell Leukemia. | J Investig Med High Impact Case Rep | 2022 | 35038889 | PubTator, text mining | PubMed |
| Early expansion of CD38+ICOS+ GC Tfh in draining lymph nodes during influenza vaccination immune response. | iScience | 2022 | 35028536 | PubTator, text mining | PubMed |
| Identification of long non-coding RNAs and RNA binding proteins in breast cancer subtypes. | Sci Rep | 2022 | 35027621 | PubTator, text mining | PubMed |
| Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. | BMC Med | 2022 | 35027067 | PubTator, text mining | PubMed |
| Evaluation of a fit-for-purpose assay to monitor antigen-specific functional CD4+ T-cell subpopulations in rheumatoid arthritis using flow cytometry-based peptide-MHC class-II tetramer staining. | Clin Exp Immunol | 2022 | 35020859 | PubTator, text mining | PubMed |
| CD116+ fetal precursors migrate to the perinatal lung and give rise to human alveolar macrophages. | J Exp Med | 2022 | 35019940 | PubTator, text mining | PubMed |
| Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environments. | J Immunother Cancer | 2022 | 35017153 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3669/papers?page=56